Wednesday, July 27, 2022 8:41:53 AM
SUPER DUPER WRONG! Please show me the long term follow up of those who were treated in Mexico. Oh wait, you won't be able to because there isn't one! The trial wasn't FDA approved. Gee, I wonder why that was the case. BAMM! So again, the disinformation in your post is just disinformation!
FACTS are stubborn things
Recent RGBP News
- Regen BioPharma Update on Orphan Drug Application for HemaXellerate Will Be Presented At Emerging Growth Conference on September 24, 2025 • GlobeNewswire Inc. • 09/23/2025 12:00:00 PM
- Regen BioPharma Prepares Response For FDA Regarding Its Orphan Drug Application for HemaXellerate • GlobeNewswire Inc. • 09/16/2025 12:00:00 PM
